These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38636325)

  • 1. PT-Finder: A multi-modal neural network approach to target identification.
    Nada H; Kim S; Lee K
    Comput Biol Med; 2024 May; 174():108444. PubMed ID: 38636325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery.
    Rifaioglu AS; Cetin Atalay R; Cansen Kahraman D; Doğan T; Martin M; Atalay V
    Bioinformatics; 2021 May; 37(5):693-704. PubMed ID: 33067636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications.
    Feinstein J; Shi W; Ramanujam J; Brylinski M
    Methods Mol Biol; 2021; 2266():299-312. PubMed ID: 33759134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving detection of protein-ligand binding sites with 3D segmentation.
    Stepniewska-Dziubinska MM; Zielenkiewicz P; Siedlecki P
    Sci Rep; 2020 Mar; 10(1):5035. PubMed ID: 32193447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GraphormerDTI: A graph transformer-based approach for drug-target interaction prediction.
    Gao M; Zhang D; Chen Y; Zhang Y; Wang Z; Wang X; Li S; Guo Y; Webb GI; Nguyen ATN; May L; Song J
    Comput Biol Med; 2024 May; 173():108339. PubMed ID: 38547658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic target identification strategy based on multi-feature learning.
    Chen L; Gu R; Li Y; Liu H; Han W; Yan Y; Chen Y; Zhang Y; Jiang Y
    J Biomol Struct Dyn; 2024 Jul; 42(11):5946-5962. PubMed ID: 37827992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QPoweredCompound2DeNovoDrugPropMax - a novel programmatic tool incorporating deep learning and
    Geoffrey A S B; Madaj R; Valluri PP
    J Biomol Struct Dyn; 2023 Mar; 41(5):1790-1797. PubMed ID: 35007471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
    Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
    AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC3i-Finder: A Machine Learning-based Computational Tool to Screen for HDAC3 Inhibitors.
    Li S; Ding Y; Chen M; Chen Y; Kirchmair J; Zhu Z; Wu S; Xia J
    Mol Inform; 2021 Mar; 40(3):e2000105. PubMed ID: 33067876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying drug-target interactions via heterogeneous graph attention networks combined with cross-modal similarities.
    Jiang L; Sun J; Wang Y; Ning Q; Luo N; Yin M
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35224614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-training graph neural networks for link prediction in biomedical networks.
    Long Y; Wu M; Liu Y; Fang Y; Kwoh CK; Chen J; Luo J; Li X
    Bioinformatics; 2022 Apr; 38(8):2254-2262. PubMed ID: 35171981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
    Raschka S; Kaufman B
    Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NerLTR-DTA: drug-target binding affinity prediction based on neighbor relationship and learning to rank.
    Ru X; Ye X; Sakurai T; Zou Q
    Bioinformatics; 2022 Mar; 38(7):1964-1971. PubMed ID: 35134828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery.
    Lin S; Shi C; Chen J
    BMC Bioinformatics; 2022 Sep; 23(1):367. PubMed ID: 36071406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. InMut-finder: a software tool for insertion identification in mutagenesis using Nanopore long reads.
    Song R; Wang Z; Wang H; Zhang H; Wang X; Nguyen H; Holding D; Yu B; Clemente T; Jia S; Zhang C
    BMC Genomics; 2021 Dec; 22(1):908. PubMed ID: 34923956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeepDTA: deep drug-target binding affinity prediction.
    Öztürk H; Özgür A; Ozkirimli E
    Bioinformatics; 2018 Sep; 34(17):i821-i829. PubMed ID: 30423097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning prediction of oncology drug targets based on protein and network properties.
    Dezső Z; Ceccarelli M
    BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ReSimNet: drug response similarity prediction using Siamese neural networks.
    Jeon M; Park D; Lee J; Jeon H; Ko M; Kim S; Choi Y; Tan AC; Kang J
    Bioinformatics; 2019 Dec; 35(24):5249-5256. PubMed ID: 31116384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.